Literature DB >> 2894570

Blood pressure, erythropoietin, and nitric oxide.

J Martin, S Moncada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2894570     DOI： 10.1016/s0140-6736(88)91438-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

Authors:  F T Ruschitzka; R H Wenger; T Stallmach; T Quaschning; C de Wit; K Wagner; R Labugger; M Kelm; G Noll; T Rülicke; S Shaw; R L Lindberg; B Rodenwaldt; H Lutz; C Bauer; T F Lüscher; M Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits.

Authors:  K Noguchi; S Yamashiro; T Matsuzaki; M Sakanashi; J Nakasone; K Miyagi; M Sakanashi
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

3.  Subcutaneous recombinant erythropoietin in preterminal renal insufficiency.

Authors:  C Van Geet; M Van Dyck; W Proesmans
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

4.  Activation of the β-common receptor by erythropoietin impairs acetylcholine-mediated vasodilation in mouse mesenteric arterioles.

Authors:  Cody R Kilar; YanPeng Diao; Larysa Sautina; Sivakumar Sekharan; Shahar Keinan; Bianca Carpino; Kirk P Conrad; Rajesh Mohandas; Mark S Segal
Journal:  Physiol Rep       Date:  2018-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.